נוגדנים לngf עם יציבות מוגברת vivo in
The present invention provides anti-nerve growth factor (NGF) antibodies that contain an IgG4 constant region comprising a stabilizing hinge region mutation and wherein the antibodies exhibit an unexpectedly long serum half life in cynomolgus monkeys. Pharmaceutical compositions comprising the anti-...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English Hebrew |
Published |
29.10.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides anti-nerve growth factor (NGF) antibodies that contain an IgG4 constant region comprising a stabilizing hinge region mutation and wherein the antibodies exhibit an unexpectedly long serum half life in cynomolgus monkeys. Pharmaceutical compositions comprising the anti-NGF antibodies, nucleic acids encoding the NGF antibodies, host cells for expressing the NGF antibodies and methods of using the antibodies for treating NGF-related diseases or conditions are also provided. |
---|---|
Bibliography: | Application Number: IL20110216128 |